{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T16:49:48Z","timestamp":1742402988998,"version":"3.37.3"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007184","name":"Yale School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007184","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.cct.2024.107657","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T19:30:30Z","timestamp":1722886230000},"page":"107657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The combination of donepezil and cognitive training for improving treatment outcomes for alcohol use disorder: Design of a randomized controlled trial"],"prefix":"10.1016","volume":"145","author":[{"given":"Gihyun","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Sofuoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismene L.","family":"Petrakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morris D.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cct.2024.107657_bb0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.15288\/jsad.2009.70.516","article-title":"Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials","volume":"70","author":"Magill","year":"2009","journal-title":"J. Stud. Alcohol Drugs"},{"issue":"2","key":"10.1016\/j.cct.2024.107657_bb0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00952990.2018.1528265","article-title":"State-of-the-art behavioral and pharmacological treatments for alcohol use disorder","volume":"45","author":"Ray","year":"2019","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.cct.2024.107657_bb0015","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/08897077.2015.1133472","article-title":"Potential medications for the treatment of alcohol use disorder: an evaluation of clinical efficacy and safety","volume":"37","author":"Litten","year":"2016","journal-title":"Subst. Abus."},{"author":"NIAAA","key":"10.1016\/j.cct.2024.107657_bb0020"},{"key":"10.1016\/j.cct.2024.107657_bb0025","first-page":"78","article-title":"Cognitive impairments in alcohol-dependent subjects","volume":"5","author":"Bernardin","year":"2014","journal-title":"Front. Psych."},{"issue":"3","key":"10.1016\/j.cct.2024.107657_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1064-1297.10.3.193","article-title":"Neurocognitive impairment associated with alcohol use disorders: implications for treatment","volume":"10","author":"Bates","year":"2002","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.cct.2024.107657_bb0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/02791072.1989.10472155","article-title":"Neurocognitive impairment: the unrecognized component of dual diagnosis in substance abuse treatment","volume":"21","author":"Meek","year":"1989","journal-title":"J. Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.cct.2024.107657_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/0894-4105.16.1.74","article-title":"A profile of neuropsychological deficits in alcoholic women","volume":"16","author":"Sullivan","year":"2002","journal-title":"Neuropsychology"},{"issue":"2","key":"10.1016\/j.cct.2024.107657_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.addbeh.2004.05.019","article-title":"Memory, executive cognitive function, and readiness to change drinking behavior","volume":"30","author":"Blume","year":"2005","journal-title":"Addict. Behav."},{"issue":"2","key":"10.1016\/j.cct.2024.107657_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12160-009-9093-8","article-title":"The role of executive cognitive functions in changing substance use: what we know and what we need to know","volume":"37","author":"Blume","year":"2009","journal-title":"Ann. Behav. Med."},{"issue":"2","key":"10.1016\/j.cct.2024.107657_bb0055","first-page":"317","article-title":"Neurotoxicity and neurocognitive impairments with alcohol and drug-use disorders: potential roles in addiction and recovery","volume":"25","author":"Bowden","year":"2001","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.cct.2024.107657_bb0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1037\/a0018058","article-title":"Computer-assisted cognitive rehabilitation for the treatment of patients with substance use disorders: a randomized clinical trial","volume":"18","author":"Fals-Stewart","year":"2010","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.cct.2024.107657_bb0065","doi-asserted-by":"crossref","first-page":"625","DOI":"10.15288\/jsad.2012.73.625","article-title":"Cognitive remediation therapy during treatment for alcohol dependence","volume":"73","author":"Rupp","year":"2012","journal-title":"J. Stud. Alcohol Drugs"},{"issue":"7","key":"10.1016\/j.cct.2024.107657_bb0070","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/0956797611412392","article-title":"Getting a grip on drinking behavior: training working memory to reduce alcohol abuse","volume":"22","author":"Houben","year":"2011","journal-title":"Psychol. Sci."},{"issue":"1","key":"10.1016\/j.cct.2024.107657_bb0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/acer.13910","article-title":"Working memory training in alcohol use disorder: a randomized controlled trial","volume":"43","author":"Khemiri","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"12","key":"10.1016\/j.cct.2024.107657_bb0080","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1037\/ccp0000312","article-title":"A randomized controlled trial of inhibitory control training for the reduction of alcohol consumption in problem drinkers","volume":"86","author":"Jones","year":"2018","journal-title":"J. Consult. Clin. Psychol."},{"issue":"6","key":"10.1016\/j.cct.2024.107657_bb0085","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1037\/neu0000575","article-title":"Cognitive training as a component of treatment of alcohol use disorder: a review","volume":"33","author":"Nixon","year":"2019","journal-title":"Neuropsychology"},{"issue":"1","key":"10.1016\/j.cct.2024.107657_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2003.11.080","article-title":"Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer\u2019s disease","volume":"486","author":"Liston","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.cct.2024.107657_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gps.993","article-title":"Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson\u2019s disease","volume":"19","author":"Leroi","year":"2004","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.cct.2024.107657_bb0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jns.2005.08.021","article-title":"Effects of donepezil on memory and cognition in multiple sclerosis","volume":"245","author":"Christodoulou","year":"2006","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.cct.2024.107657_bb0105","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/gps.1679","article-title":"A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement","volume":"22","author":"Sampson","year":"2007","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.cct.2024.107657_bb0110","first-page":"54","article-title":"Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial","volume":"40","author":"Doraiswamy","year":"2007","journal-title":"Psychopharmacol. Bull."},{"issue":"6","key":"10.1016\/j.cct.2024.107657_bb0115","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1440-1819.2003.01174.x","article-title":"Donepezil-responsive alcohol-related prolonged delirium","volume":"57","author":"Hori","year":"2003","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.cct.2024.107657_bb0120","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1176\/appi.ajp.2015.14101249","article-title":"Brain development in heavy-drinking adolescents","volume":"172","author":"Squeglia","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.cct.2024.107657_bb0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1196\/annals.1308.028","article-title":"Adolescence and the trajectory of alcohol use: basic to clinical studies","volume":"1021","author":"Brown","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"9","key":"10.1016\/j.cct.2024.107657_bb0130","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/acer.13160","article-title":"Learning and memory in adolescent moderate, binge, and extreme-binge drinkers","volume":"40","author":"Nguyen-Louie","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"5","key":"10.1016\/j.cct.2024.107657_bb0135","doi-asserted-by":"crossref","first-page":"749","DOI":"10.15288\/jsad.2012.73.749","article-title":"Brain response to working memory over three years of adolescence: influence of initiating heavy drinking","volume":"73","author":"Squeglia","year":"2012","journal-title":"J. Stud. Alcohol Drugs"},{"issue":"1","key":"10.1016\/j.cct.2024.107657_bb0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.drugalcdep.2013.05.024","article-title":"Binge drinking trajectory and neuropsychological functioning among university students: a longitudinal study","volume":"133","author":"Mota","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.cct.2024.107657_bb0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.addbeh.2011.09.015","article-title":"Executive functioning and alcohol binge drinking in university students","volume":"37","author":"Parada","year":"2012","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.cct.2024.107657_bb0150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s12640-018-9913-3","article-title":"Protective effects of donepezil against alcohol-induced toxicity in cell culture: role of Caspase-3","volume":"34","author":"Getachew","year":"2018","journal-title":"Neurotox. Res."},{"issue":"4","key":"10.1016\/j.cct.2024.107657_bb0155","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/acer.13599","article-title":"Donepezil reverses dendritic spine morphology adaptations and Fmr1 epigenetic modifications in Hippocampus of adult rats after adolescent alcohol exposure","volume":"42","author":"Mulholland","year":"2018","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.cct.2024.107657_bb0160","doi-asserted-by":"crossref","first-page":"12110","DOI":"10.1038\/s41598-019-47039-1","article-title":"Changes in Neuroimmune and neuronal death markers after adolescent alcohol exposure in rats are reversed by donepezil","volume":"9","author":"Swartzwelder","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cct.2024.107657_bb0165","series-title":"Measuring Alcohol Consumption","article-title":"Timeline follow-back: A technique for assessing self-reported alcohol consumption","author":"Sobell","year":"1992"},{"year":"2006","series-title":"MINI International Neuropsychiatric Inter-View","author":"Sheehan","key":"10.1016\/j.cct.2024.107657_bb0170"},{"year":"2001","series-title":"Wechsler Test of Adult Reading","author":"Wechsler","key":"10.1016\/j.cct.2024.107657_bb0175"},{"issue":"8","key":"10.1016\/j.cct.2024.107657_bb0260","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1530-0277.1999.tb04349.x","article-title":"Psychometric properties of the Penn alcohol craving scale","volume":"23","author":"Flannery","year":"1999","journal-title":"Alcohol. Clin. Exp. Res."},{"year":"1997","series-title":"WAIS-III Manual: Wechsler Adult Intelligence Scale-III","author":"Wechsler","key":"10.1016\/j.cct.2024.107657_bb0265"},{"issue":"2","key":"10.1016\/j.cct.2024.107657_bb0220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/13854049108403297","article-title":"The Hopkins verbal learning test: development of a new memory test with six equivalent forms","volume":"5","author":"Brandt","year":"1991","journal-title":"Clin. Neuropsychol."},{"year":"1987","series-title":"The Wechsler Memory Scale-Revised","author":"Wechsler","key":"10.1016\/j.cct.2024.107657_bb0270"},{"year":"1997","series-title":"Brief Visual Spatial Memory Test-Revised","author":"Benedict","key":"10.1016\/j.cct.2024.107657_bb0275"},{"year":"1981","series-title":"The Wisconsin Card Sorting Test Manual","author":"Heaton","key":"10.1016\/j.cct.2024.107657_bb0280"},{"issue":"3","key":"10.1016\/j.cct.2024.107657_bb0285","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11414-006-9025-3","article-title":"Reliability and validity of the BASIS-24 mental health survey for whites, african-americans, and latinos","volume":"33","author":"Eisen","year":"2006","journal-title":"J Behav Health Serv Res"},{"key":"10.1016\/j.cct.2024.107657_bb0230","series-title":"The Veterans RAND 12 Item Health Survey (VR-12): What it Is and how it Is Used, CHQOERs VA Medical Center","first-page":"1","author":"Iqbal","year":"2007"},{"year":"2007","series-title":"Bell Object Relations and Reality Testing Inventory: BORRTI","author":"Bell","key":"10.1016\/j.cct.2024.107657_bb0290"},{"year":"2010","series-title":"Measuring Health and Disability: Manual for WHO Disability Assessment Schedule WHODAS 2.0","author":"\u00dcst\u00fcn","key":"10.1016\/j.cct.2024.107657_bb0225"},{"issue":"1","key":"10.1016\/j.cct.2024.107657_bb0235","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.psychres.2008.06.018","article-title":"Validity of cognitive complaints in substance-abusing patients and non-clinical controls: the Patient\u2019s assessment of own functioning inventory (PAOFI)","volume":"169","author":"Richardson-Vejlgaard","year":"2009","journal-title":"Psychiatry Res."},{"issue":"17","key":"10.1016\/j.cct.2024.107657_bb0180","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cct.2024.107657_bb0185","first-page":"343","article-title":"SAFTEE: a technique for the systematic assessment of side effects in clinical trials","volume":"22","author":"Levine","year":"1986","journal-title":"Psychopharmacol. Bull."},{"issue":"8","key":"10.1016\/j.cct.2024.107657_bb0190","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archpsyc.58.8.763","article-title":"Neurocognitive enhancement therapy with work therapy: effects on neuropsychological test performance","volume":"58","author":"Bell","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2024.107657_bb0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1037\/prj0000211","article-title":"A randomized controlled trial of cognitive remediation and work therapy in the early phase of substance use disorder recovery for older veterans: neurocognitive and substance use outcomes","volume":"40","author":"Bell","year":"2017","journal-title":"Psychiatr. Rehabil. J."},{"issue":"5","key":"10.1016\/j.cct.2024.107657_bb0200","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/add.16109","article-title":"Cognitive training and remediation interventions for substance use disorders: a Delphi consensus study","volume":"118","author":"Verdejo-Garcia","year":"2023","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.cct.2024.107657_bb0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11065-016-9338-9","article-title":"Enhancing cognitive functioning in Healthly older adults: a systematic review of the clinical significance of commercially available computerized cognitive training in preventing cognitive decline","volume":"27","author":"Shah","year":"2017","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.cct.2024.107657_bb0210","article-title":"A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence","volume":"Suppl (15)","author":"Pettinati","year":"2005","journal-title":"J. Stud. Alcohol"},{"key":"10.1016\/j.cct.2024.107657_bb0215","first-page":"1","article-title":"Donepezil and cognitive remediation therapy to augment treatment of alcohol use disorder related mild cognitive impairment (AUD-MCI): an open label pilot study with historical controls","author":"Bell","year":"2020","journal-title":"Subst. Abus."},{"issue":"10","key":"10.1016\/j.cct.2024.107657_bb0240","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.59.10.877","article-title":"Mediators and moderators of treatment effects in randomized clinical trials","volume":"59","author":"Kraemer","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.cct.2024.107657_bb0245","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1530-0277.2010.01290.x","article-title":"Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials","volume":"34","author":"Falk","year":"2010","journal-title":"Alcohol. Clin. Exp. Res."},{"year":"2006","series-title":"Medical review of Vivitrol: 21\u2013897","author":"FDA","key":"10.1016\/j.cct.2024.107657_bb0250"},{"issue":"3","key":"10.1016\/j.cct.2024.107657_bb0255","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1369-1600.2012.00454.x","article-title":"Medications development to treat alcohol dependence: a vision for the next decade","volume":"17","author":"Litten","year":"2012","journal-title":"Addict. Biol."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424002404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424002404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T04:36:48Z","timestamp":1726375008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714424002404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":58,"alternative-id":["S1551714424002404"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2024.107657","relation":{},"ISSN":["1551-7144"],"issn-type":[{"type":"print","value":"1551-7144"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combination of donepezil and cognitive training for improving treatment outcomes for alcohol use disorder: Design of a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2024.107657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107657"}}